Clinical Trial Update: Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating the safety of anticoagulation in adults with atrial fibrillation; it is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Atrial Fibrillation (AF) | Phase 2 | Status: RECRUITING